1. Market Research
  2. > Therapy Industry

therapeutics Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Cloud Computing, Clinical Trial, Infectious Disease, Diagnostics, Medical Device, Anti-Infective, Blood Disease, Autoimmune Disease, Dermatological Condition, Neurological Disorder, Cancer, Pharmaceutical, Digestive System Disorder, Cardiovascular Disease, In Vitro Diagnostic Reagent, Eye Disease, Lymphoma, Respiratory Disease, Genitourinary System Disease.


 
1-10 of about 1600 reports for therapeutics

Purchase Reports From Reputable Market Research Publishers

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Halozyme Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Opexa Therapeutics, Inc.

Opexa Therapeutics, Inc.

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Opexa Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Nektar Therapeutics

Nektar Therapeutics

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Nektar Therapeutics compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review

Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2017
  • by Global Data

Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

Trillium Therapeutics Inc (TR) - Financial and Strategic SWOT Analysis Review

Trillium Therapeutics Inc (TR) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2017
  • by Global Data

Trillium Therapeutics Inc (TR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

D.Western Therapeutics Institute Incorporation

D.Western Therapeutics Institute Incorporation

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for D.Western Therapeutics Institute Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

United Therapeutics Corporation, Wright Investors' Service

United Therapeutics Corporation, Wright Investors' Service

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Celldex Therapeutics, Incorporation

Celldex Therapeutics, Incorporation

  • $ 87
  • Company report
  • January 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Celldex Therapeutics, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Acromegaly and Gigantism Therapeutics - Epidemiology Forecast To 2023

Acromegaly and Gigantism Therapeutics - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Acromegaly and Gigantism Therapeutics - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Acromegaly and Gigantism Therapeutics in seven major markets ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.